Moberg Pharma AB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

3 in Phase 3

Quick facts

Phase 3 pipeline

K301 · Dermatology
K301 is a topical antimicrobial agent designed to treat fungal nail infections by inhibiting fungal growth and promoting nail healing.
MOB015B · Dermatology
MOB015B is a topical antimicrobial agent designed to treat fungal nail infections by inhibiting fungal growth and promoting nail clearance.
MOB015B vehicle · Dermatology
MOB015B is a topical vehicle formulation designed to enhance drug delivery and penetration through the skin barrier.

Phase 2 pipeline

K40a
K40b
MOB015

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Moberg Pharma AB portfolio CI brief
Moberg Pharma AB pipeline updates RSS

Frequently asked questions about Moberg Pharma AB

What is Moberg Pharma AB's pipeline?

Moberg Pharma AB has 3 drugs in Phase 3, 3 in Phase 2, 0 in Phase 1. Late-stage candidates include K301, MOB015B, MOB015B vehicle.

Sector hub: All tracked pharma companies